Park Hotels & Resorts Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Park Hotels & Resorts Inc. Common Stock trades at $15.12 (market cap $3.14B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Park Hotels & Resorts Inc. Common Stock is the larger of the two by market cap, and Park Hotels & Resorts Inc. Common Stock pays a 6.41% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Park Hotels & Resorts Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| PK | VIR | |
|---|---|---|
Market Cap | $3.14B | $1.80B |
Volume | 3,553,985 | 1,782,836 |
Sector | Real Estate | Health |
52-Week High | $16.17 | $11.78 |
52-Week Low | $9.84 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.98B | $1.36B |
Dividend Yield | 6.41% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Park Hotels & Resorts Inc. is a US lodging REIT, spun off from Hilton Worldwide in 2017, that owns a portfolio of premium-branded hotels and resorts in major urban, resort, and convention markets.
Read more on PK →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →